{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:15:54Z","timestamp":1789917354786,"version":"4.0.1"},"reference-count":11,"publisher":"Elsevier BV","content-domain":{"domain":["clineu-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clineuro.2013.09.027","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T09:35:46Z","timestamp":1386495346000},"page":"S79-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"S1","title":["Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis"],"prefix":"10.1016","volume":"115","author":[{"given":"Uro\u0161","family":"Rot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka Horvat","family":"Ledinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2013.09.027_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1212\/WNL.58.2.169","article-title":"Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines","volume":"58","author":"Goodin","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0010","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.53.8.1622","article-title":"Multiple sclerosis: side effects of interferon beta therapy and their management","volume":"53","author":"Walther","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.33588\/rn.5101.2010188","article-title":"Livedo reticularis following subcutaneous injection of interferon beta-1b","volume":"51","author":"Rodriguez-Vico","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0020","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60005-0","article-title":"Severe Raynaud's phenomenon associated with interferon-\u03b2 treatment for multiple sclerosis","volume":"352","author":"Linden","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1352458509104593","article-title":"Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report","volume":"15","author":"Ledinek","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000335064","article-title":"Sildanefil therapy for interferon-beta-1a-induced pulmonary arterial hypertension: a case report","volume":"120","author":"Caravita","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0035","first-page":"S227","article-title":"A case of thrombotic microangiopathy associated with subcutaneous beta-1a-interferon therapy","volume":"17","author":"Bensa","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0060","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/1352458512441272","article-title":"Arterial hypertension induced by interferon beta 1b in a patient with multiple sclerosis","volume":"18","author":"Modrego","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0045","doi-asserted-by":"crossref","first-page":"e26568","DOI":"10.1371\/journal.pone.0026568","article-title":"Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice","volume":"6","author":"Jongen","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0050","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0014-2999(99)00107-7","article-title":"Interferon alpha elevates pulmonary blood pressure in sheep \u2013 the role of thromboxane cascade","volume":"370","author":"Hanaoka","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clineuro.2013.09.027_bib0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/ard.2009.121400","article-title":"Type I interferon system activation and association with disease manifestations in systemic sclerosis","volume":"69","author":"Eloranta","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846713003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846713003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T23:19:53Z","timestamp":1746055193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846713003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":11,"alternative-id":["S0303846713003818"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2013.09.027","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2013.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}